Results 81 to 90 of about 67,779 (243)

Ionizable Lipid Containing Nanocarriers for Antimicrobial Agent Delivery

open access: yesSmall Science
Antimicrobial resistance (AMR) poses a global health crisis demanding innovative solutions. Traditional antibiotics, though pivotal over the past century in combating bacterial infections, face diminished efficacy against evolving bacterial defense ...
Haitao Yu   +9 more
doaj   +1 more source

Population pharmacokinetics and dose optimization of piperacillin-tazobactam in premature and term neonates with severe infections

open access: yesAntimicrobial Agents and Chemotherapy
Piperacillin-tazobactam is widely used off-label in neonates for the empirical treatment of severe infections, resulting in diverse dosing regimens across clinical settings.
Frida S. Boer-Pérez   +9 more
doaj   +1 more source

Results of the effectiveness of two piperacillin–tazobactam molecules in the real world

open access: yesInternational Journal of Infectious Diseases, 2018
Objective: The objective was to determine the effectiveness of two piperacillin–tazobactam molecules in terms of all-cause mortality, mortality by infection, and hospital stay.
Jorge Enrique Machado-Alba   +2 more
doaj   +1 more source

The effects of far‐UVC irradiation on the presence and concentration of ESKAPEE pathogens on hospital surfaces: Study protocol for a multi‐site, double‐blinded randomized controlled trial in La Paz, Bolivia

open access: yesPhotochemistry and Photobiology, EarlyView.
The protocol of a multi‐site, double‐blinded, clustered randomized controlled trial (cRCT) with a binary outcome of the presence of viable presumptive ESKAPEE pathogens on surfaces in and around hospital sinks is to be implemented in two Bolivian hospitals.
Lindsay B. Saber   +14 more
wiley   +1 more source

Electrolytes imbalance: a rare side effect of piperacillin/ tazobactam therapy.

open access: yes, 2010
Electrolytes imbalance has been reported with the use of several antimicrobials. We report a case of severe hypokalemia secondary to piperacillin/tazobactam in a patient with normal renal function and normal serum potassium level who had presented with a
Baloch, K, Syed, S, Hussain, Shakir
core   +5 more sources

A case report of severe drug-induced immune hemolytic anemia caused by piperacillin

open access: yesFrontiers in Immunology
Piperacillin is a beta-lactamase inhibitor frequently used in the treatment of urinary tract infections. It is a broad-spectrum antibiotic with strong antibacterial action against Pseudomonas aeruginosa and Enterobacter, especially extended-spectrum beta-
Hong Zhao   +6 more
doaj   +1 more source

Population Pharmacokinetics of Piperacillin Using Scavenged Samples From Preterm Infants [PDF]

open access: yes, 2012
Piperacillin is often used in preterm infants for intra-abdominal infections; however, dosing has been derived from small single-center studies excluding extremely preterm infants at highest risk for these infections.
Sullivan, Janice E.   +10 more
core   +1 more source

Piperacillin enhances the inhibitory effect of tazobactam on β-lactamase through inhibition of organic anion transporter 1/3 in rats

open access: yesAsian Journal of Pharmaceutical Sciences, 2019
To assess the mechanism of the pharmacokinetic interaction between piperacillin and tazobactam, renal excretion and pharmacokinetic studies of piperacillin/tazobactam were investigated in normal and bacteremia rats.
Shilei Yang   +10 more
doaj   +1 more source

Etiology, pathogenesis and treatment of peri‐implantitis: A European perspective

open access: yesPeriodontology 2000, EarlyView.
Abstract Peri‐implantitis is a plaque‐associated pathological condition occurring in tissues around dental implants. It is characterized by inflammation in the peri‐implant mucosa and progressive loss of supporting bone. Over the last 30 years, peri‐implantitis has become a major disease burden in dentistry.
Tord Berglundh   +3 more
wiley   +1 more source

Mystery and misery of locally‐delivered drug therapy in periodontics. Historical concepts and current state

open access: yesPeriodontology 2000, EarlyView.
Abstract The primary objective is to critically analyze approaches to local therapy for periodontal disease, particularly in light of its well‐established systemic implications. We specifically address common misconceptions and overestimations regarding the potential of local treatments in contrast to their actual clinical effectiveness.
Andrea Mombelli, Alkisti Zekeridou
wiley   +1 more source

Home - About - Disclaimer - Privacy